Spironolactone in dermatology: uses in acne and beyond.

T N Searle, F Al-Niaimi, F R Ali

Review Clinical and experimental dermatology 2020 20 citations

<\/script>\n

`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D32844462'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Study Design

Study Type: Review
Population: Female pattern hair loss patients

Intervention: Spironolactone in dermatology: uses in acne and beyond. None
Comparator: None
Primary Outcome: None
Effect Direction: Negative
Risk of Bias: Unclear

Abstract

Spironolactone is a synthetic aldosterone receptor antagonist, with a role off-label in various dermatological conditions. Its antiandrogenic properties make it suitable for diseases in which excess androgen production results in unwanted and psychologically distressing manifestations in susceptible females. Treatment with spironolactone aims to attenuate androgen-mediated conditions including acne, hidradenitis suppurativa, female pattern hair loss and hirsutism. We discuss the emerging utility of spironolactone in dermatology, its potential adverse effects and considerations for monitoring.

TL;DR

Treatment with spironolactone aims to attenuate androgen‐mediated conditions including acne, hidradenitis suppurativa, female pattern hair loss and hirsutism.

Used In Evidence Reviews

A Spironolactone for Female Pattern Hair Loss

Spironolactone in dermatology: uses in acne and beyond.

Embed This Widget

Study Design

Abstract

TL;DR

Used In Evidence Reviews

Similar Papers

Evaluation and treatment of male and female pattern hair loss.

Treatment of female pattern hair loss with oral antiandrogens.

Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.

Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.

Hair regrowth. Therapeutic agents.

Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia.